Llwytho...
The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis
BACKGROUND: Oral disease-modifying therapies offer equivalent or superior efficacy and greater convenience versus injectable options. OBJECTIVES: To compare patient-reported experiences of fingolimod and dimethyl fumarate. METHODS: Adult relapsing-remitting multiple sclerosis patients treated with f...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | BMC Res Notes |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioMed Central
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5015319/ https://ncbi.nlm.nih.gov/pubmed/27604188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-016-2243-8 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|